Gilead Goes Full Steam Ahead In Oncology With Big Lung Cancer Push
Islatravir/Lenacapavir Program Under Way Again
In its third quarter earnings, Gilead highlighted its drug development efforts in oncology, infectious and inflammatory diseases • Source: Shutterstock
